SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
即时热点
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Seeone
Lv7
1
3798 积分
2022-08-01 加入
最近求助
最近应助
互助留言
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update
27天前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
1个月前
已完结
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial
1个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Fundamentals of Clinical Trials
2个月前
已关闭
Celiac plexus radiosurgery for pain management in advanced cancer: a multicentre, single-arm, phase 2 trial
2个月前
已完结
Incidence of antibody–drug conjugates-related pneumonitis in patients with solid tumors: A systematic review and meta-analysis
2个月前
已完结
Bystander effect of antibody–drug conjugates: fact or fiction?
4个月前
已完结
Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction?
4个月前
已完结
Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients
4个月前
已完结
没有进行任何应助
点赞
27天前
点赞
4个月前
多位应助者表示官网无补充材料【积分已退回】
5个月前
需要的是补充材料,谢谢
5个月前
需要的是补充材料,谢谢
5个月前
速度真快
5个月前
点赞
5个月前
点赞
5个月前
感谢
6个月前
点赞
7个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论